A long term follow up study for a comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine and symptoms or based on symptoms only ('Children Asthma Therapy Optimal')

Trial Profile

A long term follow up study for a comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine and symptoms or based on symptoms only ('Children Asthma Therapy Optimal')

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Mar 2012

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms CATO
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 16 Jun 2011 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
    • 07 Mar 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top